Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 202
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00940680 | Efficacy/Safety of Amlodipine Plus Losartan Versus Losartan in Patients With Essential Hypertension | ||
| NCT03330327 | Molar Potency Study of HM12470 in Healthy Subjects | ||
| NCT07359105 | Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study) | ||
| NCT02473900 | Evaluating the Bioequivalence of HIP1403, HGP0919 | ||
| NCT05199129 | Clinical Efficacy and Safety Evaluation of HCP1904-3 in Essential Hypertension Patients | ||
| NCT04167553 | Study for Multiple Doses of HM15136(Efpegerglucagon) in Obese or Overweight Subjects With Comorbidities | ||
| NCT03882112 | Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy Male Subjects | ||
| NCT02075281 | Effect of LAPS-Exendin on Body Weight in Obese Population | ||
| NCT07379333 | A Study to Evaluate Efficacy and Safety of HM11260C in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin | ||
| NCT05845489 | Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION) | ||
| NCT02941731 | Evaluating the Bioequivalence of HIP1403 and HGP0919 Suspensions | ||
| NCT04252872 | Pharmacokinetics of HCP1401 and Co-administration of HCP0605, HGP1405 in Healthy Male Volunteers | ||
| NCT05462535 | An Observational Study to Evaluate Effectiveness and Safety of Amosartan Plus Tablet | ||
| NCT03479073 | Risk Factors of Stroke or Systemic Embolism After Atrial Fibrillation Ablation | ||
| NCT01913847 | Safety and Efficacy Study of HGP1207 in Patients With Pulmonary Hypertension | ||
| NCT01491503 | A Drug Interaction Study of Montelukast and Levocetirizine | ||
| NCT01197014 | A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan | ||
| NCT03353350 | Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise | ||
| NCT04829149 | Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration in Patients With Dyslipidemia in Korea | ||
| NCT00954304 | Duration of P-glycoprotein Inhibition After Oral Administration of HM30181AK Tablet | ||
| NCT05555238 | An Observational Study to Evaluate the Treatment of Newvast® Tab(Atorvastatin) in Korean Patients With Dyslipidemia | ||
| NCT01764087 | A Study of KX2-391 With Paclitaxel in Patients With Solid Tumors | ||
| NCT05548387 | A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers | ||
| NCT04252963 | Clinical Trial to Assess the Efficacy and Safety of MUCOLASE Tablet(Streptokinase • Streptodornase) | ||
| NCT02523547 | Study to Evaluate the Non-inferiority of Cavir in HBeAg(+)Chronic Hepatitis B Patients Treated With Baraclude | ||
| NCT04652349 | Efficacy and Safety of HGP1910 and HCP1903 in Patients With Primary Hypercholesterolemia | ||
| NCT00979563 | Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies | ||
| NCT01718847 | NOV120101 Phase 2 Study in NSCLC Patients With Aquired Resistance to 1st Generation EGFR Tyrosine Kinase Inhibitors | ||
| NCT06724016 | Dose Escalation and Expansion Study of HM16390 Alone or With Pembrolizumab in Advanced or Metastatic Solid Tumors | ||
| NCT05723549 | A Study to Evaluate the PK, Safety and Tolerability of HCP1803. | ||
| NCT02140489 | Evaluating a Pharmacokinetic Drug Interaction Between Amlodipine/Losartan and Rosuvastatin | ||
| NCT02899455 | Clinical Efficacy and Safety Evaluation of Co-administered HGP0904, HGP0608 and HGP0816 in Patients With Hypertension and Dyslipidemia | ||
| NCT04830449 | Clinical Efficacy and Safety Evaluation of HCP1904-2 in Essential Hypertension Patients | ||
| NCT03372850 | Safety, Pharmacokinetics and Pharmacodynamics of the Two Esomeprazole Formulations | ||
| NCT02552667 | Efficacy and Safety of HCP1102 Capsule | ||
| NCT05737082 | A Study to Evaluate the Pharmacokinetics and Safety Between HCP2201 and Co-administration of Each Component in Healty Male Volunteers | ||
| NCT01447797 | A Bioequivalence Study Comparing Irbesartan/Atorvastatin Combination Tablet With Coadministration of Irbesartan and Atorvastatin | ||
| NCT04324918 | Efficacy and Safety of HCP1102 Capsule in Patients With Perennial Allergic Rhinitis | ||
| NCT01509196 | A Bioequivalence Study Comparing HIP0901 Capsule With Lipidilsupra Tablet | ||
| NCT00998283 | Assess the Safety, Tolerability, and Pharmacokinetic (PK) Characteristics of HM10460A (HNK460) in Healthy Adult Korean Subjects | ||
| NCT06438172 | A Study to Evaluate Efficacy and Safety of HCP1803 Compared to RLD2001-1 in Patients with Essential Hypertension | ||
| NCT01505777 | Exploratory Clinical Study to Evaluate the Optimal Dosage of Mosapride and Probiotics in Irritable Bowel Syndrome Without Predominant Diarrhea | ||
| NCT05487560 | An Observational Study to Evaluate the Incidence of MACCE According to Time Interval of Taking Medication in Patients With Acute Coronary Syndrome or Cerebral Infarction Who Received DAPT for the Secondary Prevention and Esomezol Cap for the Prevention of Gastrointestinal Bleeding | ||
| NCT04820907 | Clinical Efficacy and Safety Evaluation of HCP1904-1 in Essential Hypertension Patients | ||
| NCT05450575 | An Observational Study to Evaluate Effectiveness and Safety of Amosartan Q Tablet | ||
| NCT04732416 | HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI) | ||
| NCT01093729 | A Study of HM11260C in Healthy Male Subject | ||
| NCT03684642 | Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin | ||
| NCT02554136 | Evaluating a Pharmacokinetic Drug Interaction Between HGP0918 and HGP0816 | ||
| NCT02302443 | A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12470 |
